185 related articles for article (PubMed ID: 35523938)
1. Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization.
Kafeero HM; Ndagire D; Ocama P; Kato CD; Wampande E; Walusansa A; Kajumbula H; Kateete D; Sendagire H
Sci Rep; 2022 May; 12(1):7425. PubMed ID: 35523938
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
Wang Y; Shu M; Chen J; Shen F; Ren H; Yu Y
Front Public Health; 2023; 11():1302183. PubMed ID: 38179572
[TBL] [Abstract][Full Text] [Related]
3. HBsAg (-)/HBsAb (-)/HBeAg (-)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B-cell lymphoma receiving rituximab based immunochemotherapy.
Shui LP; Zhu Y; Duan XQ; Chen YT; Yang L; Tang XQ; Zhang HB; Xiao Q; Wang L; Liu L; Luo XH
J Med Virol; 2023 Feb; 95(2):e28549. PubMed ID: 36734081
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto Nigeria.
Erhabor O; Mohammad SY; Bello L; Onuigwe FU; Abdulrahman Y; Zama I; Buhari H; Bagudo A; Ibrahim K; Ahmed M; Udomah FP; Adias TC; Erhabor T; Okara GC
Hum Antibodies; 2020; 28(3):233-243. PubMed ID: 32333583
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Hepatitis B Virus Infection Markers among Patients of the Ibn Sina University Hospital Center (Rabat, Morocco).
Feindiri M; Kabbaj H; El Mzibri M; Belkadi B; Bouihat N; Filali-Maltouf A; Seffar M
Intervirology; 2022; 65(2):80-86. PubMed ID: 34518480
[TBL] [Abstract][Full Text] [Related]
6. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
Sanders RC; Lewis D; Dyke T; Alpers MP
P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China.
Jin Y; Geng N; Zhao L; Li Y; Zheng L; Zhu W; Sheng Q; An Z; Wang J; Dou X; Bai H
Viral Immunol; 2020 Mar; 33(2):99-104. PubMed ID: 31834847
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
Chen YM; Chen HH; Huang WN; Chen YH; Hsieh TY; Yang SS; Lan JL; Chen DY
Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
[TBL] [Abstract][Full Text] [Related]
10. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
[TBL] [Abstract][Full Text] [Related]
11. Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
Malamba SS; Muyinda H; Ogwang DM; Katamba A; Zamar DS; Jongbloed K; Sewankambo NK; Schechter MT; Spittal PM
PLoS One; 2021; 16(5):e0251573. PubMed ID: 34043637
[TBL] [Abstract][Full Text] [Related]
12. Positive Rate of Different Hepatitis B Virus Serological Markers in Peking Union Medical College Hospital, a General Tertiary Hospital in Beijing.
Zhang Y; Bian S; Liu X; Xu S; Zhang L; Zhou B; Zhang W; Zhang Y; Xu Y; Deng G
Chin Med Sci J; 2016 Mar; 31(1):17-2. PubMed ID: 28031083
[TBL] [Abstract][Full Text] [Related]
13. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
Tien YC; Yen HH; Li CF; Liu MP; Hsue YT; Hung MH; Chiu YM
Arthritis Res Ther; 2018 Nov; 20(1):246. PubMed ID: 30382902
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.
Lô G; Sow-Sall A; Diop-Ndiaye H; Babacar N; Diouf NN; Daffé SM; Ndao B; Thiam M; Mbow M; Soumboundou MB; Lemoine M; Sylla-Niang M; Ndiaye O; Boye CS; Mboup S; Touré-Kane NC
Pan Afr Med J; 2019; 32():140. PubMed ID: 31303913
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
[TBL] [Abstract][Full Text] [Related]
16. SEROEPIDEMIOLOGY OF HBV ANTIGEN AND ANTI-HCV AMONG GENERAL POPULATION IN A RURAL LOCAL IN BAUCHI STATE, NIGERIA.
Alkali M; Okon KO; Umar MS; Sani MD; Shuaibu H; Babale RS; Sani M; Mohammed GH; Tar B; Amadu L
West Afr J Med; 2023 Dec; (12 Suppl 1):S33-S34. PubMed ID: 38070129
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological and clinical profile of pediatric hepatitis B virus infections in Wuhan: a retrospective cohort study.
Wang J; Huang YG; Zeng Y; Cai QZ; Wu M; Shen X; Tuo WB; Xie S; Ma X; Xiang Y; Yuan CH; Yao C
BMC Pediatr; 2023 Dec; 23(1):636. PubMed ID: 38104124
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.
Attia KA; Eholié S; Messou E; Danel C; Polneau S; Chenal H; Toni T; Mbamy M; Seyler C; Wakasugi N; N'dri-Yoman T; Anglaret X
World J Hepatol; 2012 Jul; 4(7):218-23. PubMed ID: 22855697
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
Fang J; Li W; Peng X; Tan Z; Tan M; Zhang C; Wang W; Xu Z; Zhou G
Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
